At a glance
ClinicalIndex Comparison RecordN/ACompleted· 130 enrolled
Drug / intervention
Lithium treatmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Genetic Studies of Psychiatric Illness
In Brief
An observational study evaluating Lithium treatment for Bipolar Disorder. Completed, enrolled 130 participants across 1 site.
Detailed Summary
The purpose of this study is to identify genetic predictors of lithium response in bipolar disorder.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2005
First PostedNov 2005
Primary CompletionMar 2016
Study CompletionMay 2016
TodayJul 2026
First PostedNov 11, 2005
Enrollment StartOct 1, 2005
Primary CompletionMar 1, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10.4 yearsPosted 20.6 years ago
Interventions
Lithium treatmentdrug
Lithium is a standard treatment for bipolar disorder. Patients will be stabilized on lithium monotherapy over a 3 month period, observed for one month, and then followed every 2 months in maintenance phase for 2 years